Oramed Announces Dual-Listing on Tel Aviv Stock Exchange
Oramed Pharmaceuticals Inc. (ORMP)
Last oramed pharmaceuticals inc. earnings: 4/6 04:46 pm
Check Earnings Report
US:NASDAQ Investor Relations:
oramed.com/investors
Company Research
Source: PR Newswire
JERUSALEM, July 5, 2017 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has received approval from the Israel Securities Authority to dual-list its common stock on the Tel Aviv Stock Exchange (TASE). Oramed common stock will commence trading on the TASE on July 12, 2017 under the ticker ORMP. Based on the current market capitalization of the Company, it is expected that Oramed will be included in the TA SME-60 index.Oramed common stock will continue to be listed and traded on the NASDAQ Capital Markets and the Company will continue to comply with the regulations of the U.S. Securities and Exchange Commission. Per the TASE's listing requirements and Israel's Dual Listing Law, U.S. listed companies may dual-list on the TASE without any additional regulatory reporting or requirements. "We believe dual-listing on the TASE will provide many
Show less
Read more
Impact Snapshot
Event Time:
ORMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORMP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORMP alerts
High impacting Oramed Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
ORMP
News
- Scilex Holding repays the remaining balance of convertible debentures [Seeking Alpha]Seeking Alpha
- Oramed Letter to Shareholders [Yahoo! Finance]Yahoo! Finance
- Oramed Letter to ShareholdersPR Newswire
ORMP
Earnings
- 11/9/23 - Beat
ORMP
Sec Filings
- 3/22/24 - Form SC
- 3/19/24 - Form 8-K
- 3/18/24 - Form 8-K
- ORMP's page on the SEC website